BrainStorm Cell Therapeutics
BCLI
#10412
Rank
HK$46.44 M
Marketcap
HK$4.21
Share price
-3.57%
Change (1 day)
-73.24%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -HK$84.54 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$90.6 Million, an increase over its 2023 earnings that were of -HK$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$84.54 Million-6.68%
2024 -HK$90.6 Million-32.39%
2023 -HK$0.14 Billion-29.18%
2022 -HK$0.19 Billion-0.74%
2021 -HK$0.2 Billion-23.12%
2020 -HK$0.25 Billion36.8%
2019 -HK$0.19 Billion66.71%
2018 -HK$0.11 Billion181.66%
2017 -HK$38.6 Million-0.6%
2016 -HK$38.84 Million-41.31%
2015 -HK$66.16 Million-8.22%
2014 -HK$72.09 Million89.74%
2013 -HK$38 Million42.27%
2012 -HK$26.71 Million-12.45%
2011 -HK$30.5 Million63.04%
2010 -HK$18.71 Million35.52%
2009 -HK$13.81 Million-48.99%
2008 -HK$27.07 Million-44.39%
2007 -HK$48.67 Million
2005 -HK$25.2 Million-91.44%
2004 -HK$0.3 Billion94007.62%
2003 -HK$0.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
HK$77.05 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-HK$5.87 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-HK$6.17 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.84 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.16 B-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-HK$2 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA